Atopic Dermatitis

Pfizer Adds Eczema Gel With $5B Anacor Deal
Strategy

Pfizer Adds Eczema Gel With $5B Anacor Deal

If Anacor's treatment for eczema is approved by the FDA, Pfizer predicts peak-year sales could exceed $2 billion.
By Katie Kuehner-Hebert | May 16, 2016
Read More